X

Health Care

AbbVie (ABBV) Earnings: 4Q20 Key Numbers

AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today. Worldwide net revenues rose 59.2% year-over-year to $13.8 billion…

Infographic: Key financials of Biogen (BIIB) Q4 2020 earnings report

Biogen (NASDAQ: BIIB) reported fourth-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 22%…

CorVel (CRVL) expands scope of services as focus shifts to COVID care

In the pandemic-hit healthcare market, CorVel Corporation (NASDAQ: CRVL) is facing a major uncertainty that is as unsettling as the…

Pfizer Inc. (PFE) Q4 2020 Earnings Call Transcript

Pfizer Inc. (NYSE: PFE) Q4 2020 earnings call dated Feb. 02, 2021 Corporate Participants: Charles E. Triano -- Senior Vice President, Investor…

Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On…

Infographic: Vertex Pharmaceuticals (VRTX) 4Q20 Earnings Results

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today. Total revenues increased 15% year-over-year to $1.62 billion.…

Where do these companies stand in the COVID-19 vaccine race?

After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19…

Thermo Fisher Scientific (TMO) Earnings: 4Q20 Key Numbers

Thermo Fisher Scientific Inc. (NYSE: TMO) reported fourth-quarter 2020 earnings results today. Revenue increased 54% year-over-year to $10.55 billion. GAAP…

Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals

Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate.…

Cipla Limited (CIPLA) Q3 2021 Earnings Call Transcript

Cipla Limited  ( NSE : CIPLA) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Kumar Gaurav -- Vice President, Kotak…

Novavax (NVAX) brings its share to the COVID-19 vaccine table; stock soars

Novavax Inc.’s (NASDAQ: NVAX) shares soared 50% in morning hours on Friday after the company announced that its COVID-19 vaccine…

Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript

Dr. Reddy's Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal -- Head of Investor…

Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript

Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief…

Abbott Laboratories (ABT) Q4 2020 Earnings Call

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and…

Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript

Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing…

ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results

Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the…

Fate Therapeutics (FATE) looks headed for a turnaround post-COVID

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market's attention after reporting positive results from…

Novartis International AG (NVS) Q4 2020 Earnings Call Transcript

Novartis International AG (NYSE: NVS) Q4 2020 earnings call dated Jan. 26, 2021 Corporate Participants: Samir Shah -- Global Head, Investor Relations…

Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health

Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth…

Johnson & Johnson (JNJ) beats market estimates in Q4

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates

Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical…